Researchers have developed a method that links the chemical composition of cells with their gene activity to help identify senescence in mouse tissues. Published September 21 in Nature Aging, the RamanOmics study addresses a central challenge in aging biology: recognizing potentially important cell states within the tissues where they occur.

The work offers a research tool for examining how cells change with age. It does not establish a test of human biological age or demonstrate that detecting these cells improves healthspan.

Connecting chemistry with gene activity

Raman microscopy reads chemical information from the way light scatters after interacting with a sample. It can examine cellular composition without adding molecular labels. Gene-expression methods provide a complementary view, showing which biological programs are active and, with spatial techniques, where those programs occur.

The researchers combined these approaches in lung and skin from mice aged two months and 26 months, with three animals per age group for each tissue analysis. Their objective was to connect biochemical patterns with cell identities and senescence-associated gene activity, rather than measure survival or treatment benefit.

They identified a lipid-associated Raman signal shared across the two tissues in cells expressing p21, a marker used in the study to define a senescent subset. Machine learning helped combine chemical and molecular features into a classification barcode. The team also examined a mouse wound-healing model, extending the investigation beyond comparisons between young and old tissue.

Why identifying senescence is difficult

Senescence is commonly associated with cells that stop dividing while remaining metabolically active. Such cells can contribute to tissue dysfunction, but senescence also participates in normal development and repair. Detecting a senescence-associated signal therefore does not, by itself, establish that a cell is harmful or should be removed.

This measurement problem predates the new paper. Recommendations published by the SenNet Biomarkers Working Group in 2024 reviewed evidence across 14 human and mouse tissues. They emphasized the difficulty of identifying relatively rare senescent cells in tissues and the importance of using multiple detection approaches.

An accompanying Nature Aging commentary by Shuai Ma and Jing Qu places RamanOmics within that broader effort. Their central interpretation is that gene expression captures only part of senescence: changes in cellular chemistry provide another layer of information. Linking those layers could help researchers describe cell states more fully than either approach alone.

For longevity research, that distinction matters. A marker can help investigators locate or classify cells without being a validated measure of disease severity, future disability or response to treatment. Those are separate questions requiring their own studies.

Substantial barriers to human use

The study’s definition centers on p21-positive cells, so its findings cannot automatically represent every form of senescence. Limited tissue sampling and the rarity of those cells also constrain classifier development. The authors say the biological interpretation of chemical signals needs further validation.

Speed is another obstacle. According to MIT’s September 21 account, analyzing roughly one square millimeter of tissue currently takes about 30 hours. Researchers are developing faster imaging and working toward applications in human tissue. Those efforts describe the next stage of development, not an available clinical service.

The practical value today is a way to investigate aging-related cellular changes while preserving information about their location and chemistry. Before the approach could support medical decisions, researchers would need to establish how reliably it works in human specimens and whether its measurements provide information that changes care or predicts meaningful health outcomes.

Primary sourceNature Aging: RamanOmics technical report, published September 21, 2026

The source ledger and revision history are retained with the newsroom record.

AI-assisted reporting disclosure

AI assisted with source organization and drafting. Vitalspan Wire is accountable for the published text and maintains a revision record.

Medical note

This article provides general information, not diagnosis or treatment advice. Consult a qualified clinician before making medical decisions.